Chemours Co
For the period ended Mar 31, 2026. Filed May 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 5, 2026
CC$13.48+1.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Interim Consolidated Statements of Comprehensive Income (Unaudited)
(Dollars in millions)
| Three Months Ended March 31, | |||||||
|---|---|---|---|---|---|---|---|
| 2026 · 2025 | |||||||
| Pre-tax · Tax · After-tax · Pre-tax · Tax · After-tax | |||||||
| Net (loss) income | $(22) | $(7) | $(29) | $— | $(5) | $(5) | |
| Other comprehensive income (loss): | |||||||
| Hedging activities: | |||||||
| Unrealized gain (loss) on net investment hedge | $27 | $(9) | 18 | $(26) | $7 | (19) | |
| Unrealized gain (loss) on cash flow hedge | 5 | (1) | 4 | (5) | 1 | (4) | |
| Reclassifications to net income - cash flow hedge | 4 | (1) | 3 | (2) | — | (2) | |
| Hedging activities, net | 36 | (11) | 25 | (33) | 8 | (25) | |
| Cumulative translation adjustment | (26) | — | (26) | 59 | — | 59 | |
| Defined benefit plans: | |||||||
| Additions to accumulated other comprehensive income (loss): | |||||||
| Net loss | — | — | — | — | — | — | |
| Effect of foreign exchange rates | 1 | — | 1 | (2) | — | (2) | |
| Reclassifications to net income: | |||||||
| Amortization of actuarial loss | — | — | — | 1 | — | 1 | |
| Settlement gain | — | — | — | — | — | — | |
| Defined benefit plans, net | $1 | $— | 1 | $(1) | $— | (1) | |
| Other comprehensive income | — | 33 | |||||
| Comprehensive (loss) income | (29) | 28 | |||||
| Comprehensive (loss) income attributable to Chemours | $(29) | $28 | |||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.